Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,874
Closed -$214K 467
2023
Q4
$214K Buy
+1,874
New +$187K 0.01% 393
2023
Q3
Sell
-1,874
Closed -$211K 462
2023
Q2
$211K Buy
+1,874
New +$198K 0.01% 394
2023
Q1
Sell
-1,866
Closed -$206K 452
2022
Q4
$206K Buy
+1,866
New +$196K 0.01% 395
2022
Q1
Sell
-1,854
Closed -$222K 487
2021
Q4
$222K Hold
1,854
0.01% 431
2021
Q3
$229K Sell
1,854
-102
-5% -$13.1K 0.01% 414
2021
Q2
$235K Sell
1,956
-86
-4% -$9.82K 0.01% 418
2021
Q1
$215K Buy
2,042
+42
+2% +$4.26K 0.01% 407
2020
Q4
$204K Buy
+2,000
New +$188K 0.01% 403

Other funds holding XYL

Ingalls & Snyder LLC's XYL Position: Q1 2024 in Review

Ingalls & Snyder LLC sold out of Xylem (XYL) in Q1 2024, closing a stake of 1,874 shares — an estimated $214K sold.

Ingalls & Snyder LLC first reported a position in XYL in Q4 2020 and held it in 8 quarters. The position peaked at $235K in Q2 2021. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Ingalls & Snyder LLC reported no remaining Xylem position as of Q1 2024 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 1,874 Xylem shares in Q1 2024, an estimated $214K.
  • Ingalls & Snyder LLC first reported a position in Xylem in Q4 2020 and held it in 8 quarters.
  • Ingalls & Snyder LLC's Xylem position peaked at $235K in Q2 2021.
  • 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2024, filed 13 May 2024.